Thyroid disease: assessment and management (NG145)Product type:GuidanceProgramme:NICE guidelineLast updated: 12 October 2023Published: 20 November 2019
Percutaneous ultrasound-guided microwave ablation for symptomatic benign thyroid nodules (HTG646)Product type:GuidanceProgramme:HealthTech guidancePublished: 16 November 2022
High-intensity focused ultrasound for symptomatic benign thyroid nodules (HTG504)Product type:GuidanceProgramme:HealthTech guidancePublished: 27 February 2019
Vandetanib for treating medullary thyroid cancer (TA550)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 12 December 2018
Lenvatinib and sorafenib for treating differentiated thyroid cancer after radioactive iodine (TA535)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 8 August 2018
Cabozantinib for treating medullary thyroid cancer (TA516)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 28 March 2018
Ultrasound-guided percutaneous radiofrequency ablation for benign thyroid nodules (HTG416)Product type:GuidanceProgramme:HealthTech guidancePublished: 22 June 2016
Minimally invasive video-assisted thyroidectomy (HTG349)Product type:GuidanceProgramme:HealthTech guidancePublished: 23 August 2014
Intraoperative nerve monitoring during thyroid surgery (HTG164)Product type:GuidanceProgramme:HealthTech guidancePublished: 26 March 2008
Retrobulbar irradiation for thyroid eye disease (HTG94)Product type:GuidanceProgramme:HealthTech guidancePublished: 14 December 2005